EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, vol.57, no.9, pp.659-662, 2001 (SCI-Expanded)
Objectives: The objective of our study was to investigate the possible role of human arylamine N-acetyltransferase 2 (NAT2) polymorphism in susceptibility to Behcet's disease.